Lupron depot-PED 30 MG 3MO kits
Ended Awarded
- Contract number
- SPE2DB25FV0BN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,924
Award facts
- Contract value 100% obligated
- $11,923.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $11,923.84 for Lupron Depot-Ped 30 mg 3-month kits on September 11, 2025, with an ultimate completion date of September 12, 2025. This firm fixed-price, non-competitive delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Lupron Depot-Ped is a specialty pharmaceutical used in pediatric endocrinology for treating central precocious puberty, supporting the military and federal healthcare systems' medical supply requirements.
As a child delivery order under the larger SPE2DX pharmaceutical prime vendor contract, this award reflects AmerisourceBergen's role as a critical supplier of specialty medications to the Defense Health Agency and other federal healthcare entities. The company's comprehensive pharmaceutical distribution capabilities and established relationship with DLA enable efficient fulfillment of specialty medical products needed across the federal military healthcare system. This delivery order exemplifies the routine pharmaceutical procurement activities occurring under the broader global pharmaceutical support vehicle that provides flexible sourcing of brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FV0BN?
SPE2DB25FV0BN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 11, 2025.
How much is contract SPE2DB25FV0BN worth?
The government has obligated $11,924 on SPE2DB25FV0BN.
Is contract SPE2DB25FV0BN an order under another contract?
Yes. SPE2DB25FV0BN is a delivery order under SPE2DB22D1052, an indefinite delivery contract.
Was contract SPE2DB25FV0BN competed?
The extent of competition for SPE2DB25FV0BN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award